CONDITION

Feline Asthma

A chronic inflammatory condition of the airways in cats that causes breathing difficulty, wheezing, and coughing episodes.

Why this matters now

Feline asthma can present at any age, though it is most commonly recognised in young to middle-aged cats, typically between two and eight years of age. Siamese and Himalayan breeds may carry a higher predisposition, though the condition occurs across all breeds and mixed-breed cats. Environmental factors play a significant role — cats in households with indoor allergens such as dust, cigarette smoke, aerosol sprays, scented litter, or seasonal pollen exposure may be more likely to develop clinical signs. The condition shares similarities with human asthma, involving airway hyperreactivity and inflammation, and may wax and wane with environmental changes or seasonal patterns. Some cats present with acute, dramatic episodes, while others develop a chronic, low-grade cough that gradually worsens over months before veterinary attention is sought.

The course of feline asthma varies considerably between individuals. Some cats experience infrequent, mild episodes that respond well to management and remain stable for years, while others may develop progressive airway remodelling that leads to increasingly severe and frequent episodes over time. Chronic airway inflammation can lead to structural changes in the bronchial walls — thickening, increased mucus production, and smooth muscle hypertrophy — that may become partially irreversible if the condition persists untreated. The unpredictability of acute exacerbations means that a cat with seemingly well-controlled asthma can experience sudden deterioration, sometimes triggered by environmental changes that are difficult to anticipate. Long-term management typically involves ongoing monitoring and adjustment as the individual cat's pattern becomes better understood.

Signals & patterns

Early signals

Intermittent coughing episodes

One of the earliest and most common signs is a distinctive cough that may be mistaken for hairball retching. The cat typically adopts a crouched posture with neck extended and head low to the ground, producing a dry, hacking cough. These episodes may be brief and infrequent initially, occurring only occasionally and resolving spontaneously, which can delay recognition of the respiratory nature of the problem.

Subtle wheezing

A soft, high-pitched whistling sound may be audible during breathing, particularly on exhalation, reflecting narrowed airways. This wheeze can be intermittent and may only be noticed in quiet environments or when the cat is resting. Some owners describe it as a faint musical quality to the breathing that comes and goes without an obvious pattern.

Mild exercise intolerance

Cats may begin to show reduced willingness to engage in vigorous play or may tire more quickly during activity. Given that many cats are naturally sedentary, this change can be subtle and easily overlooked. Owners might notice that a cat who previously enjoyed chasing toys or climbing now prefers to observe from a resting position more frequently.

Increased respiratory rate at rest

A subtly elevated resting respiratory rate may be an early indicator of compromised airflow. Normal resting respiratory rates in cats typically fall below 30 breaths per minute, and consistent elevation above this threshold during undisturbed sleep or rest can suggest underlying respiratory compromise. This sign requires careful observation, as transient elevation from stress, warmth, or recent activity is common and does not carry the same significance.

Open-mouth breathing after exertion

While cats may occasionally pant after intense activity or in hot conditions, open-mouth breathing that occurs after only mild exertion or persists for extended periods can reflect underlying airway compromise. This sign tends to appear earlier in the course of the disease during episodes of bronchospasm, though it may resolve completely between episodes, making it easy to dismiss as situational.

Later signals

Increased frequency and severity of episodes

As airway inflammation becomes more established, coughing and wheezing episodes may occur more frequently and last longer. What began as occasional, brief episodes may evolve into daily occurrences, sometimes with multiple events throughout the day. The intensity of respiratory effort during episodes may also increase, with more pronounced abdominal effort visible during exhalation.

Laboured breathing with abdominal effort

Progressive airway obstruction can lead to visibly increased breathing effort, where the cat uses abdominal muscles to force air out through narrowed bronchi. This expiratory push creates a noticeable abdominal component to breathing that is not present in normal respiration. The combination of thoracic and abdominal movement during breathing often becomes more prominent as the condition advances.

Cyanosis during severe episodes

In more advanced cases, acute bronchospasm may compromise oxygen exchange sufficiently to produce a bluish discolouration of the gums and tongue. This reflects significant hypoxaemia and indicates that the degree of airway obstruction is substantially limiting gas exchange. The appearance of cyanosis during episodes represents a significant escalation in the severity of the respiratory compromise.

Weight loss and reduced appetite

Chronic respiratory compromise can lead to gradual weight loss as the metabolic demands of laboured breathing increase caloric expenditure, while simultaneously reducing appetite. Cats may eat smaller amounts or show less enthusiasm for food, particularly around episodes of respiratory distress. This systemic effect reflects the broader impact of poorly controlled chronic airway disease on overall wellbeing.

Click to read about the biological mechanisms

How this is usually investigated

Investigating suspected feline asthma involves distinguishing it from other conditions that can cause coughing or respiratory distress in cats, including heartworm-associated respiratory disease, bronchial neoplasia, pneumonia, and cardiac disease. The diagnostic approach typically combines imaging, laboratory analysis, and sometimes airway sampling to build a clinical picture.

Thoracic radiography

Purpose: Chest X-rays are typically the first-line imaging investigation and can reveal characteristic patterns associated with feline asthma, including bronchial wall thickening (sometimes described as 'doughnut' signs in cross-section or 'tramlines' in longitudinal view), hyperinflation of the lungs due to air trapping, and in some cases, areas of lung collapse (atelectasis) from mucus plugging.
Considerations: Radiographic changes can be subtle in mild cases, and a proportion of asthmatic cats may have apparently normal chest films, particularly between episodes. The stress of restraint for radiography can itself trigger respiratory distress in compromised patients, and some cats may require sedation or stabilisation before imaging can be safely performed. Radiographic patterns overlap with other conditions, so imaging alone is rarely definitive.

Bronchoalveolar lavage (BAL)

Purpose: BAL involves instilling and recovering a small volume of sterile saline into the airways under anaesthesia to collect cells and fluid for analysis. The cytology of recovered fluid typically shows a predominance of eosinophils in asthmatic cats, which supports the diagnosis and helps distinguish asthma from bacterial pneumonia or other inflammatory patterns. Culture of BAL fluid can also identify secondary bacterial infection that may complicate the condition.
Considerations: The procedure requires general anaesthesia, which carries inherent considerations in a patient with compromised airways. The diagnostic yield depends on technique and the specific airways sampled. Some cats with confirmed asthma may show neutrophilic rather than eosinophilic inflammation, and results can be influenced by concurrent or recent corticosteroid therapy.

Complete blood count

Purpose: A blood count may reveal peripheral eosinophilia — an elevated number of circulating eosinophils — which, while not specific to asthma, supports the presence of an allergic or parasitic inflammatory process. The degree of eosinophilia does not necessarily correlate with disease severity, but its presence in a cat with compatible respiratory signs adds weight to the clinical picture.
Considerations: Peripheral eosinophilia is present in only a proportion of cats with confirmed asthma, so a normal eosinophil count does not exclude the diagnosis. Stress can cause a transient decrease in eosinophil numbers, potentially masking eosinophilia at the time of sampling. Other conditions, particularly parasitic disease and other allergic conditions, can produce similar blood count patterns.

Heartworm testing

Purpose: Heartworm-associated respiratory disease (HARD) can produce clinical signs virtually identical to feline asthma, and cats in endemic areas may require testing to distinguish between the two conditions. Both antigen and antibody testing may be performed, as the feline heartworm testing landscape is more complex than in dogs due to lower worm burdens and different immune responses.
Considerations: The sensitivity of heartworm tests in cats is lower than in dogs, partly because cats often harbour fewer adult worms and may mount an immune response that clears the antigen. Geographic location significantly influences the pre-test probability — testing may be more relevant in endemic regions. Some cats may have both conditions concurrently, complicating interpretation.

Faecal examination

Purpose: Parasitic migration through the lungs (lungworm infection from species such as Aelurostrongylus abstrusus) can produce respiratory signs that mimic asthma, including coughing, wheezing, and eosinophilic airway inflammation. Faecal examination using Baermann technique or direct smear can identify larval stages of lung parasites.
Considerations: Larval shedding can be intermittent, meaning a single negative faecal result does not definitively exclude lungworm infection. The relevance of parasitic testing depends on the cat's lifestyle — outdoor cats with hunting behaviour carry higher risk. In some cases, empirical antiparasitic treatment may be considered alongside other diagnostic steps.

Options & trade-offs

Management of feline asthma generally aims to reduce airway inflammation and control bronchospasm through a combination of approaches. The specific combination of therapies is often tailored to the individual cat's severity, frequency of episodes, and tolerance of different treatment modalities.

Inhaled corticosteroid therapy

Inhaled corticosteroids, typically fluticasone delivered via a metered-dose inhaler and feline-specific spacer device, deliver anti-inflammatory medication directly to the airways. This approach targets the underlying inflammation at the site of disease while minimising systemic absorption and the associated side effects of oral corticosteroids. Most cats can be trained to accept the spacer and mask with patient acclimatisation over days to weeks.

Trade-offs: The initial cost of the spacer device and medication can be significant, and not all cats tolerate the mask and spacer despite training efforts. The onset of effect is slower than systemic corticosteroids, typically requiring one to two weeks to achieve clinical benefit. Proper technique — ensuring a good mask seal and adequate breath cycles — is essential for effective drug delivery and can be challenging with some patients.

Systemic corticosteroid therapy

Oral prednisolone or injectable corticosteroid preparations provide broad anti-inflammatory effects that can rapidly reduce airway inflammation and improve breathing. Oral formulations allow dose titration over time, typically starting at higher doses during acute phases and tapering to the lowest effective maintenance dose. Injectable long-acting preparations may be used when oral medication is not feasible.

Trade-offs: Systemic corticosteroids carry a wider side effect profile than inhaled preparations, including potential for diabetes mellitus induction (cats are particularly susceptible), weight gain, immunosuppression, and urinary tract complications with long-term use. Long-acting injectable forms do not allow dose adjustment once administered and provide sustained systemic exposure. The balance between effective inflammation control and minimising systemic effects often requires ongoing dose adjustment.

Bronchodilator therapy

Bronchodilators such as inhaled salbutamol (albuterol) or oral terbutaline work by relaxing airway smooth muscle, providing relief from acute bronchospasm. These medications address the bronchoconstrictive component of asthma and can provide rapid improvement in airflow during acute episodes. Inhaled bronchodilators delivered via the same spacer device used for corticosteroids offer rapid onset of action within minutes.

Trade-offs: Bronchodilators address symptoms rather than the underlying inflammation, and reliance on bronchodilators alone without anti-inflammatory therapy may allow progressive airway remodelling to continue unchecked. Side effects can include tachycardia, tremor, and restlessness, though these are typically mild and transient. The frequency of bronchodilator use can serve as an informal indicator of how well the underlying inflammation is being controlled.

Environmental modification

Reducing exposure to airborne irritants and potential allergens can play a supportive role in managing feline asthma. Common modifications include switching to dust-free or unscented litter, eliminating cigarette smoke exposure, reducing use of aerosol sprays, air fresheners, and scented candles, improving ventilation, and using air purifiers with HEPA filtration. Identifying and addressing specific environmental triggers through observation of symptom patterns can help target modifications.

Trade-offs: The specific triggers for an individual cat are often difficult to identify definitively, and complete allergen avoidance is rarely achievable in a home environment. Environmental changes alone are unlikely to provide sufficient control for moderate to severe asthma and are generally considered complementary to pharmacological management. The degree of improvement from environmental modification varies considerably between individuals, and changes may take weeks to produce observable effects.

Allergen-specific immunotherapy

In cases where intradermal or serological allergy testing identifies specific allergen sensitivities, allergen-specific immunotherapy (desensitisation) may be considered. This involves graduated exposure to identified allergens through regular injections or sublingual administration over months to years, aiming to modify the immune response and reduce hypersensitivity. The approach targets the root immune mechanism rather than managing downstream inflammation.

Trade-offs: Allergy testing in cats can produce variable results, and the correlation between identified sensitivities and clinical disease is not always straightforward. Immunotherapy requires a long-term commitment, typically requiring 6-12 months before meaningful clinical improvement may become apparent, and not all cats show a significant response. The approach is most relevant when specific environmental allergens can be identified and is generally used alongside other management strategies rather than as a sole intervention.

Common misconceptions

Misconception:

"Cats coughing up hairballs are just dealing with fur, not a respiratory condition"

Reality:

The posture and sound cats adopt during asthmatic coughing episodes closely resembles hairball retching, leading many owners to attribute the episodes to hairballs rather than respiratory disease. The crouched position with extended neck and the retching-like quality of the cough can be virtually indistinguishable from hairball production, particularly when no hairball is produced. Persistent or recurring episodes of apparent hairball retching — especially without actual hairball production — may reflect underlying airway disease rather than gastrointestinal fur accumulation.

Misconception:

"Feline asthma can be cured with the right treatment"

Reality:

Feline asthma is generally considered a chronic condition that can be effectively managed but not cured. The underlying tendency towards airway hyperreactivity and allergic inflammation tends to persist throughout the cat's life, even when clinical signs are well controlled. Management aims to minimise inflammation, prevent airway remodelling, and maintain quality of life rather than eliminate the condition entirely. Some cats may experience periods of apparent remission, but the potential for recurrence typically remains.

Misconception:

"If a cat is breathing normally between episodes, the asthma is not serious"

Reality:

The episodic nature of feline asthma can create a misleading impression that the condition is only significant during visible episodes. Between acute bronchospasm events, chronic low-grade airway inflammation may continue to cause progressive structural changes to the bronchial walls — a process that can occur silently without obvious clinical signs. This ongoing remodelling can gradually reduce the airways' ability to function normally and may make future episodes more severe, even when the cat appears comfortable between events.

Understanding feline asthma involves recognising it as a chronic condition with acute components — meaning ongoing attention to both the underlying inflammation and environmental factors tends to be part of the long-term picture. Observing patterns in when episodes occur, what environmental changes precede them, and how the cat responds to different management approaches can build valuable insight over time. The condition's similarity to human asthma means that research continues to evolve understanding of the underlying mechanisms and potential therapeutic approaches. Each cat's experience with asthma is individual, and the journey of management often involves learning what works for that particular animal through careful observation and ongoing dialogue with veterinary professionals.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS